PURI PDRN 2.5ml*5
Pharmaceutical-grade Polydeoxyribonucleotide Solution with 99.8% Bioactive Purity for Dermal Regeneration
Advanced Nucleic Acid Technology & Medical Grade Standard
PURI PDRN utilizes patented purification technology (Patent No. 7352109) to produce medical-grade polydeoxyribonucleotides under ISO 13485 certification. The solution contains 5mg/ml of bioactive PDRN fragments (500-1500Da) combined with 25mg/ml cross-linked hyaluronic acid. Third-party testing confirms 99.8% protein-free purity with <2EU/ml endotoxin levels. Clinical studies demonstrate 78% cellular uptake efficiency within 24 hours post-administration.
Clinically Validated Benefits
Dermal Density Improvement
42% increase in collagen density at 16 weeks (3D skin scanning, n=120)
Wrinkle Depth Reduction
57% decrease in vertical wrinkle depth (PRIMOS 3D analysis)
Pore Size Minimization
39% reduction in pore diameter after 4 treatments
Skin Brightening
5.1% increase in L* value (Chroma Meter CR-400 measurement)
Pharmaceutical Specifications
- Active Ingredients: PDRN 5mg/ml + HA 25mg/ml
- Packaging: 5 ampoules × 2.5ml
- Molecular Weight: 500-1500Da PDRN fragments
- Sterility: Terminal sterilization at 121°C for 15min
- Storage: 2-25°C protected from light
- Shelf Life: 24 months unopened
Clinical Protocol
- Needle Size: 31-34G (5/9 needle mesogun)
- Depth: 1.2-2.4mm (epidermal-dermal junction)
- Frequency: 2-3 week intervals
- Course: 4 sessions for optimal results
- Dosage: 0.5-1ml per treatment area
Treatment Timeline
Stage 1: Initial Treatment
First 2 sessions (2-week intervals): Immediate hydration improvement and skin texture refinement. 89% users report visible brightness improvement within 14 days.
Stage 2: Collagen Induction
Sessions 3-4 (3-week intervals): Measurable dermal thickening (avg. +0.23mm via ultrasound). 72% improvement in elasticity scores.
Maintenance Phase
Quarterly treatments: Maintains 83% of collagen gains. Combine with Potenza RF for enhanced pore reduction effect.
Medical Advisory Notice
Important: Individual results may vary based on skin type and biological response. All procedures must be performed by licensed dermatologists. Contraindications include active skin infections, pregnancy, and history of keloid formation.
Not recommended for patients undergoing radiation therapy. Post-treatment erythema typically resolves within 24-48 hours. Discontinue use if persistent edema or hypersensitivity occurs.
Reviews
There are no reviews yet.